Phase III, Open-label Study of Nilotinib Versus Imatinib in GIST Patients - No Study Results Posted

Phase III, Open-label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)

This study is ongoing, but not recruiting participants.

Study NCT00785785 Information provided by Novartis

First Received: November 4, 2008 Last Updated: October 4, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2021 (Final data collection date for primary outcome measure)